{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-25-003837","form_type":"8-K","ticker":"LFWD","cik":"0001607962","company_name":"Lifeward Ltd.","filed_at":"2025-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.909283+00:00","generated_at":"2026-05-16T19:51:42.503808+00:00","sec_items":["1.01","2.02","2.03","3.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lifeward Q3 revenue $6.2M (+1% YoY); net loss $0.20/shr; secures $3M loan from Oramed","bullets":["Revenue $6.2M (+1% YoY); traditional products up 24% to $3.1M; AlterG down 15% to $3.1M.","GAAP net loss $3.2M ($0.20/shr); non-GAAP net loss $3.0M ($0.19/shr) vs $4.0M ($0.45/shr) YoY.","Cash used in ops $3.8M (down from $4.5M YoY); unrestricted cash $2.0M at quarter end.","Entered $3.0M secured loan from Oramed at 15%, convertible at $0.45/shr, matures May 2026.","Reaffirmed FY2025 guidance: revenue $24-26M; non-GAAP net loss $12-14M."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-25-003837","json":"https://secwatch.observer/filing/0001178913-25-003837.json","markdown":"https://secwatch.observer/filing/0001178913-25-003837.md","text":"https://secwatch.observer/filing/0001178913-25-003837.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1607962/000117891325003837/0001178913-25-003837-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1607962/000117891325003837/zk2534022.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:51:42.503808+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"07002d8a88245288ed801eabfe7dc2df652def4d","claim":"Lifeward Ltd. incurred loan of $3.0 million with Oramed Ltd. at 15% per annum maturing May 14, 2026.","evidence_excerpt":"On November 14, 2025, Lifeward Ltd. (the “Company,” “we” or “us”) entered into a Secured Promissory Note (the “Secured Promissory Note”) with Oramed Ltd. (“Oramed”) pursuant to which, we issued to Oramed a secured promissory note in the principal amount of $3.0 million.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1607962/000117891325003837/0001178913-25-003837-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$3.0 million"},{"label":"Counterparty","value":"Oramed Ltd."},{"label":"Rate","value":"15% per annum"},{"label":"Maturity","value":"May 14, 2026"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}